COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

Visit COSMED @ Hall 1 - booth # 1.52  during the 40th ISICEM International Symposium in Brussels the 24th to the 27nd of March 2020.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

Visit COSMED #booth 606 during the ASPEN 2020 Nutrition Science & Practice Conference in Tampa, FL from the 28th to the 31st of March 2020.

Visit COSMED Booth #D75 - Halle 8 during the FIBO Trade Show in Cologne (2 –5 April 2020).